Ekso Bionics (NASDAQ: EKSO) reported Q3 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $4.5 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.